GI neoplasms 1 Flashcards

1
Q

SB is ____% of GI with only ___% of tumors

most common is the ____

A

75%

3-6%

Adenoma near ampula

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Risk factors for SI adenocarcinoma

A

Crohns/ Adenomas/ Celiac/ Familial polyposis Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

most common non-epi tumor of GI, from Cajal cells (mesenchymal)

A

GIST

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

GIST is seen in which syndromes:

A

Seen in: Carney triad/ Neurofibromatosis/ Carney-Stratakis syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Treatement for GIST tumors

A

Tx: Gleevac (bc of c-kit mutation seen in 85% = tyrosine kinase and is a driver mutation. PDGFRA same)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Location of GIST tumors

A

Location:

60% stomach/

30% sm.intestine

4% colon:

with a glossy grayish color

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Key histological markers in GIST

Histology: test + for ckit = CD117 in almost 100% cases

DOG1

CD34 (90% time)—> shows up dark stain

Also has different muscle markers: actin, desmin, S-100

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pt comes in with tumors in the small intestine and your Preceptor states it is ammendable to Gleevac for tx. What type of markers would you expect it to have?

A

This is a GIST tumor; c-kit positive (tyr/kinase), DOG1 and CD34 +

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Tumor that secreates bioactives = vasomotor/flushing/hepatomegaly and increase serotonin 5-HT

A

carcinoid tumor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Where are carcinoid tumors commonly located in the intetinal tract?

A

located in WALL of intestine; presents as submucosal nodule. Mass of neuroendocrine cells pushing upward

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What levels will be elevated in a pt with carcinoid tumor?

A

Seratonin: 5-HT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

epithelium derived tumor mass, protrudes through lumen: either pedunculate or sessile

A

Intestinal Polyp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

d/t abnormal mucosal maturation, inflammation, fucked arch. NO MALIG potential

A

Non-neoplastic =

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

d/t proliferation+dysplasia (adenomas) and is precursor to carcinoma

A

Neoplastic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

benign, focal mass with mature, histologically normal elements in disorganized manner

A

Hamartoma: non neoplastic polyp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are my 3 non-neoplastic polyps?

A

Hamartomatous

Inflammatory

Lymphoid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

seen in kids

A

Juvenile polyps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe what a juvenile polyp looks like histologically

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is Juvenile polyposis syndrome?

Where is it located?

What gene mutation?

A

multple polyps >5: in stomach/sm.intest/colon/rectum

        **Auto. Dominant** of **SMAD4, BMPR1A**, r*isk of adenomas,* 10-50% lifetime risk colon,  gastric, small intestine and pancreas cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

multple polyps >5: in stomach/sm.intest/colon/rectum

        Auto. Dominant of SMAD4, BMPR1A, risk of adenomas, 10-50% lifetime risk colon,  gastric, small intestine and pancreas cancer
A

Juvenile polyposis Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Peutz-Jeghers Polyps:____ malignant potential

A

no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Pt has hyperpigmented mouth and fingers and multple GI polyps. Dx and inheritance pattern?

A

Peutyz-Jegher Syndrome = STK11; auto-Dominant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are risks associated with Peutz-Jeghers Syndrome?

A

Risk intussusseption.

Risk of cancer of: pancrease/breast/ovary/uterus/lung of 50% lifetime risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Describe what you see on histology and what disease this is assoicated with

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
hamartomous GI polpys with facial trichilemmomas, oral papillomas, acral keratoses.
Cowden syndrome
26
Pt has Cowden syndrome. What is the inheritance pattern? What are associated risks? What is the maligant potential?
Cowden = hamartomatous polyps, Autosomal Dominant Assoicated with thyroid and breast cancer polyps have no maligant potential
27
non-hereditary, GI hamartomas, Ectodermal shit: nail atrophy + alopecia 2. Inflammatory polyps: pseudopolyps—regenarating mucosa next to ulceration (seen in bad IBD) 3. Lymphoid polyps: mucosal bumps, d/t intramucosal lymphoid follicles; NORMAL
Cronkite-Canada
28
pseudopolyps—regenarating mucosa next to ulceration (seen in bad IBD)
Inflammatory polyps
29
mucosal bumps, d/t intramucosal lymphoid follicles; NORMAL
Lymphoid polyps
30
Two types of serrated polyps
Hyperplastic and Sessile serrated
31
32
Describe location, histology and maligant potential of Hyperplastic Serrated polyps
Distally located no maligant potential make up 60-90% of serrated polyps and grow upward so deep, narrow stalk
33
Describe location, maligant potential and histology of Sessile Serrated polyps
more proximally located HIGH malignant potetial: BRAF V600 mutation; methlyation --+/- microsatalite instability Look like flasks on histology bc grow horizontal and verticle
34
epithelial proliferative dysplasia + precursor to adenocarcinoma ## Footnote
Adenomatous Polpys; adenomas
35
Three types of adenoma polpys
36
Epidemiology for Adenomatous polyps
seen in 40-60% population \>60. Familial pattern; 4x risk of devo adenoma if 1st degree relative had one Adenoma has 4x increase risk of devoing carcinoma with M=F
37
What do Tubular adenoma's look like and where are they found?
small, pedunculate w/ 90% in colon. Can be mult or single IG
38
Describe the histology of tubular adenomas
-dysplastic epithelium: elongated, pseudostratified, HYPERchromatic nuclei, loss of mucin production
39
lots of projections, large and sessile, no stalk, seen in OLDER peep in RECTOsigmoid
Villious Adenoma:
40
Describe histology of villous adenoma why is there such high maligant potential?
-no stalk to act as buffer in case of invasive carcinoma—\> invasion directly into colon wall —up to 10cm diameter; see fungating and slightly raised for gross
41
Tubular adenoma; rare to get cancer if \_\_\_\_\_ Risk approaches ____ in sessile, villous adnomas \>4cm; high grade dysplasia if present IG in\_\_\_\_\_ areas but also found in any polyp
\<1cm 40% villious
42
Intramucosal carcinoma = invades LP but
NO malignant potential
43
Invasive carcionoma IN a pedunuclated adenoma that has gone through muscularis: endoscopic removal is enough IF what 3 critera are met
resection margins are negative no lymph or vascular invasion carcinoma not poorly different
44
Invasive carcinoma in **Sessile** polyp: polypectomy\_\_\_\_\_, need partial colectomy
inadequte \*\*\*regardless of carcinoma presence, only tx for adenoma is complete resection!
45
Colorectal Cancer epidemiology
98% adnocarcinoma 9% of all cancer deaths in US Peak incidicend is 90% over age 50 99% occur singly 1-3% familila or IBD most in rectosigmoid, followed by cecum and ascending
46
Colorectal cancers causes fatige, weak, Fe anemia. More common in cecum, slow bleed causing progressive weakness. D/t polypoid or exophytic lesions
Right Sided (non-obstructive) colorectal cancer
47
What type of lesions commonly seen with right sided CRC?
polypoid or exophytic
48
Colorectal cancer that is obstructive, get occult bleed, change in bowel habits, ab discomfort and **Annular ‘napkin’ obstruction**. More **infiltrative**
Left sided: (obstructive) CRC
49
Male comes in that is in his 60s and has been tiring easily and feels weak. His labs show Fe deficinecy anemia. What do we need to rule out?
Dx as colon cancer till proven otherwise; often has aysmptomatic and insidious onset
50
51
Population w/ high prevelance of adenomas = high chance of\_\_\_\_ cancer distribution of polyps and cancer in colorectal is simular Peak age for adenomas anteda\_\_\_tes peak age for cancer; if you find cancer early, often see adenomatous tissue surrounding it Cancer risk is\_\_\_\_\_ related to # adenomas; will get cancer with FAP; thus remove polyps!
colorectal colorectal DIRECTLY
52
Explain pathogenesis of CRC
Multi-hit hypothesis; accumulation of mutations (more important than order) with the last to accumlate is p53
53
\>80% colon cancer has inactivated\_\_\_\_ and 50% w/out ACP have ____ mutations (10%) ## Footnote
ACP B-catenin
54
—dysfnx of APC seen in colorectal cancer leads to
increased WNT signaling, decreased cell adhesions, increase cell proliferate
55
Not frequent, but hard to identify grossly, associated with Ulcerative colitis, aggressive, spread early
Infiltrative colorectal cancer
56
Staging based on depth of invasion; T1 = T2= T3= Stage = T+N+M
1 = Submucosa 2= muscularis propria 3= Serosa
57
Stage 0 = Stage I: Stage II: Stage III:
Stage 0 = in situ carcinoma Stage I: T1, T2, N0, M0 Stage II: T2 or T4, NO, MO Stage III: any T, positive Nodes StageIV-mets I and II can be cured by excision III need adjuvant therapy IV is palliative care
58
Single most important prognostic indicator of colorectal carcinoma is
extent or STAGE at time of dx
59
Survival rates for Colorectal Carcinoma
I and II = 93 and 85% 5 yr surival Stage II = 70% stage IV= 8%
60
Where do CRC mets genrally go to?
Direct extension to adjacent structures. Mets via LN then to liver, lungs, bones 25-30% pts have METS when they present
61
Options for targeted therapy in mCRC
Targeted Therapy: to the tumor cell w/ Bevacizumab, Cetuximab, Pantiumamb
62
\_\_\_\_\_\_ gives info about pt overall outcome, regardless of therapy \_\_\_\_\_\_: info about effects of particular therapeutic intervention
Prognostic: Predictive:
63
activation stims key processes in tumor growth & progression; key for proliferation, angiogenesis, invasion, metastasis
EGFR
64
What 3 major pathways are activated in EGFR?
RAS-RAF-MAP kinase PI3K-AKT PLC-gamma that are overexposed in range of solid tumors: there is a transmembrane domain and intracellular domain
65
What are our key EGFRs involved in colon and breast cancer?
ErbB1/EGFR/Her1 in colon B2/Her2/Neu in breast
66
What happens in EGFR signal transduction?
turn on STAT or RAS/RAF/MAPK path to induce gene transcription = **anti-apoptosis, metastasis, angiogenesis and proliferation and maturation**
67
Monoclonal anti-EGFR tx:\_\_\_\_\_ and\_\_\_\_\_\_ used in treatement but no correlation with EGFR expression and response: Doesn’t work for pts with\_\_\_\_ mutation bc that’s downstream
Cetuximab pantumumab KRAS
68
There is a lack of correlation btween anti-EGFR therapy and
EGFR expression
69
If a patient has ______ then giving them anti-EGFR mAB won't help their cancer
KRAS
70
this mutant tumor is associated with lower progression free surival and overall survival compated to WT tumor
BRAF mutant
71
how don't does the anti-EGFR therapy work?
only for 12-18 months and only in tumors that don't have downstream effector molecule mutations
72
\_\_\_\_\_mutaiton is major NEGATIVE predictor for efficacy in EFGR therapy and\_\_\_\_ correlates w/ poor prognosis
KRAS BRAF